{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:08:27Z","timestamp":1772431707845,"version":"3.50.1"},"reference-count":46,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the clinical trial center of the Second Affiliated Hospital of Wenzhou Medical University","award":["SAHoWMU-CR2017-07-101"],"award-info":[{"award-number":["SAHoWMU-CR2017-07-101"]}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20170604"],"award-info":[{"award-number":["Y20170604"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Uterine fibroids are the most common pelvic benign tumour with no satisfactory long-term medical treatment. Recent studies have demonstrated that vitamin D significantly inhibited the growth of fibroids in vitro, vivo and a small-sample clinical trial. Therefore, the aim of this randomised clinical trial (RCT) is to evaluate whether supplementation with vitamin D could reduce the risk and inhibit the growth of uterine fibroids in reproductive stage women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The open-label, RCT comprises two parts, including parts I and II. In part I, 2230 vitamin D deficiency or vitamin D insufficiency patients without uterine fibroids will be randomly assigned to two groups: intervention group (according to the level of serum 25-hydroxyvitamin D<jats:sub>3<\/jats:sub>, receive 1600 or 800\u2009IU\/day of vitamin D<jats:sub>3<\/jats:sub> for 2 years) and control group (followed up at the same time points). By using gynaecological ultrasound examinations, the incidence of uterine fibroids will be employed to measure the outcome in different groups. In part II, 360 uterine fibroids patients with vitamin D deficiency or vitamin D insufficiency will be randomly assigned to intervention group or control group. According to the level of serum 25-hydroxyvitamin D<jats:sub>3<\/jats:sub>, 180 patients will receive 1600 or 800\u2009IU\/day of vitamin D<jats:sub>3<\/jats:sub> for 2 years. Control group will receive regular follow-up. The outcome measure will be conducted using gynaecological ultrasound examinations to detect the growth of uterine fibroids in each group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This study has been approved by the institutional review board of the Second Affiliated Hospital of Wenzhou Medical University (No. LCKY2018-35).<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration numbers<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03586947\">NCT03586947<\/jats:ext-link> and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03584529\">NCT03584529<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038709","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T21:27:30Z","timestamp":1604698050000},"page":"e038709","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Association between vitamin D and uterine fibroids: a study protocol of an open-label, randomised controlled trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03586947","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03584529","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03586947","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03584529","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bo","family":"Sheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizuo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-928X","authenticated-orcid":false,"given":"Xueqiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2021070402250636000_10.11.e038709.1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"2021070402250636000_10.11.e038709.2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11255-016-1248-5","article-title":"Urological complications of uterine leiomyoma: a review of literature","volume":"48","author":"Dagur","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"2021070402250636000_10.11.e038709.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30338-8"},{"key":"2021070402250636000_10.11.e038709.4","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw023"},{"key":"2021070402250636000_10.11.e038709.5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2015.09.006","article-title":"Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones","volume":"105","author":"Malik","year":"2016","journal-title":"Fertil Steril"},{"key":"2021070402250636000_10.11.e038709.6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17460441.2018.1417381","article-title":"Successes and failures of uterine leiomyoma drug discovery","volume":"13","author":"Ali","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"2021070402250636000_10.11.e038709.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.08.039"},{"key":"2021070402250636000_10.11.e038709.8","article-title":"Different dosages of mifepristone versus enantone to treat uterine fibroids: a multicenter randomized controlled trial","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"2021070402250636000_10.11.e038709.9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006680","article-title":"The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas","volume":"96","author":"Shen","year":"2017","journal-title":"Medicine"},{"key":"2021070402250636000_10.11.e038709.10","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv030"},{"key":"2021070402250636000_10.11.e038709.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2379"},{"key":"2021070402250636000_10.11.e038709.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.2.513"},{"key":"2021070402250636000_10.11.e038709.13","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"4","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021070402250636000_10.11.e038709.14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/13543784.2018.1471134","article-title":"Vilaprisan for treating uterine fibroids","volume":"27","author":"Melis","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"2021070402250636000_10.11.e038709.15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/01635581.2015.1015746","article-title":"Dietary components and uterine leiomyomas: a review of published data","volume":"67","author":"Parazzini","year":"2015","journal-title":"Nutr Cancer"},{"key":"2021070402250636000_10.11.e038709.16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122586","article-title":"Alternative oral agents in prophylaxis and therapy of uterine Fibroids-An up-to-date review","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2021070402250636000_10.11.e038709.17","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31828acca0"},{"key":"2021070402250636000_10.11.e038709.18","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.fertnstert.2016.09.007","article-title":"Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids","volume":"106","author":"Ciebiera","year":"2016","journal-title":"Fertil Steril"},{"key":"2021070402250636000_10.11.e038709.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.136"},{"key":"2021070402250636000_10.11.e038709.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2131"},{"key":"2021070402250636000_10.11.e038709.21","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.111.098145"},{"key":"2021070402250636000_10.11.e038709.22","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114537721"},{"key":"2021070402250636000_10.11.e038709.23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2018.10.008","article-title":"Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt\/\u03b2-catenin pathway","volume":"111","author":"Corach\u00e1n","year":"2019","journal-title":"Fertil Steril"},{"key":"2021070402250636000_10.11.e038709.24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2019.09.018","article-title":"Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model","volume":"113","author":"Corach\u00e1n","year":"2020","journal-title":"Fertil Steril"},{"key":"2021070402250636000_10.11.e038709.25","article-title":"The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"2021070402250636000_10.11.e038709.26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005698","article-title":"Hypovitaminosis D and \u201csmall burden\u201d uterine fibroids: Opportunity for a vitamin D supplementation","volume":"95","author":"Ciavattini","year":"2016","journal-title":"Medicine"},{"key":"2021070402250636000_10.11.e038709.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101159","article-title":"Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial","volume":"39","author":"Arjeh","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"2021070402250636000_10.11.e038709.28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.fertnstert.2015.05.031","article-title":"Role of vitamin D in uterine fibroid biology","volume":"104","author":"Brakta","year":"2015","journal-title":"Fertil Steril"},{"key":"2021070402250636000_10.11.e038709.29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.04.008","article-title":"The role of vitamin D in the endocrinology controlling calcium homeostasis","volume":"453","author":"Fleet","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2021070402250636000_10.11.e038709.30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5114\/aoms.2017.68237","article-title":"Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk","volume":"13","author":"Faridi","year":"2017","journal-title":"Arch Med Sci"},{"key":"2021070402250636000_10.11.e038709.31","doi-asserted-by":"publisher","DOI":"10.1177\/1933719117715124"},{"key":"2021070402250636000_10.11.e038709.32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0385"},{"key":"2021070402250636000_10.11.e038709.33","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.115.129478"},{"key":"2021070402250636000_10.11.e038709.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306357"},{"key":"2021070402250636000_10.11.e038709.35","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu093"},{"key":"2021070402250636000_10.11.e038709.36","first-page":"1011","article-title":"Application guideline for vitamin D and bone health in adult Chinese (2014 standard edition)","volume":"20","author":"Liao","year":"2014","journal-title":"Chinese Journal of Osteoporosis"},{"key":"2021070402250636000_10.11.e038709.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1389"},{"key":"2021070402250636000_10.11.e038709.38","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.17380","article-title":"Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in patients with type 2 diabetes: a randomized clinical trial","volume":"322","author":"de Boer","year":"2019","journal-title":"JAMA"},{"key":"2021070402250636000_10.11.e038709.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11889"},{"key":"2021070402250636000_10.11.e038709.40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/jama.2019.2210","article-title":"Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: the AMATERASU randomized clinical trial","volume":"321","author":"Urashima","year":"2019","journal-title":"JAMA"},{"key":"2021070402250636000_10.11.e038709.41","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.2178","article-title":"Monthly high-dose vitamin D supplementation and cancer risk: a post hoc analysis of the vitamin D assessment randomized clinical trial","volume":"4","author":"Scragg","year":"2018","journal-title":"JAMA Oncol"},{"key":"2021070402250636000_10.11.e038709.42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.8708"},{"key":"2021070402250636000_10.11.e038709.43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx235"},{"key":"2021070402250636000_10.11.e038709.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2115"},{"key":"2021070402250636000_10.11.e038709.45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011732"},{"key":"2021070402250636000_10.11.e038709.46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00246","article-title":"Vitamin D supplementation guidelines for general population and groups at risk of vitamin D deficiency in Poland-Recommendations of the Polish Society of pediatric endocrinology and diabetes and the expert panel with participation of national specialist consultants and representatives of scientific Societies-2018 update","volume":"9","author":"Rusi\u0144ska","year":"2018","journal-title":"Front Endocrinol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T09:25:35Z","timestamp":1625390735000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,6]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjopen-2020-038709"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038709","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}